College of Pharmacy
Kandukuru Lab
Led by Abhishek Kandukuru · Pharmacy(unverified)
What we study
The Kandukuru Lab studies drug safety through pharmacovigilance, mining the FDA Adverse Event Reporting System with disproportionality statistics to look for heart-related risks of medications such as citalopram, triptans, testosterone and glaucoma drugs.
What working here is like
- Computational
- Human participants
- Coding helps
- Project
- 1
- Papers
- 4
Current projects
Project A disproportionality analysis of cardiac adverse events associated to citalopram treating Alzheimer's Disease in the FDA Adverse Event Reporting System
The lab mined FDA adverse‑event reports to see if citalopram is linked to heart problems in Alzheimer’s patients, using reporting odds ratios, proportional reporting ratios, and Bayesian information components, and compared risks across age groups and genders. The student carried out the data extraction and signal‑detection calculations.
From the Spring 2025 UF Undergraduate Research Symposium · abstract book, p. 303
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
Recent papers, explained
- Myocardial Infarction, Pulmonary Embolism, and Deep Vein Thrombosis Following Testosterone Cypionate Use: A Pharmacovigilance Study
2026 · Current Drug Safety
Analyzes cardiovascular risks linked to testosterone cypionate use.
- CARDIOVASCULAR ADVERSE EVENTS ASSOCIATED WITH ANTIGLAUCOMA MEDICATIONS: A PHARMACOVIGILANCE STUDY OF THE FDA ADVERSE EVENT REPORTING SYSTEM
2025 · Journal of the American College of Cardiology
Show 2 more papersShow fewer
- Cardiovascular adverse events associated with triptans for treatment of migraine: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)
2024 · Canadian Journal of Physiology and Pharmacology
Examines cardiovascular risks from triptan migraine treatments.
- Cardiovascular adverse events associated with norepinephrine–dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System
2024 · Canadian Journal of Physiology and Pharmacology
Investigates cardiovascular risks from norepinephrine-dopamine inhibitors.
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Abhishek Kandukuru hasn't set up this page yet. You can also look them up in the UF directory (search “Abhishek Kandukuru”).